NGM Biopharmaceuticals, Inc. Revenue 2018-2023 | NGM
NGM Biopharmaceuticals, Inc. revenue from 2018 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| NGM Biopharmaceuticals, Inc. Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $4 |
| 2022 | $55 |
| 2021 | $78 |
| 2020 | $87 |
| 2019 | $104 |
| 2018 | $109 |
| 2017 | $77 |
| NGM Biopharmaceuticals, Inc. Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2023-12-31 | $0 |
| 2023-09-30 | $1 |
| 2023-06-30 | $1 |
| 2023-03-31 | $2 |
| 2022-12-31 | $18 |
| 2022-09-30 | $8 |
| 2022-06-30 | $8 |
| 2022-03-31 | $21 |
| 2021-12-31 | $21 |
| 2021-09-30 | $19 |
| 2021-06-30 | $17 |
| 2021-03-31 | $22 |
| 2020-12-31 | $20 |
| 2020-09-30 | $23 |
| 2020-06-30 | $20 |
| 2020-03-31 | $24 |
| 2019-12-31 | $31 |
| 2019-09-30 | $22 |
| 2019-06-30 | $25 |
| 2019-03-31 | $26 |
| 2018-12-31 | $47 |
| 2018-09-30 | $21 |
| 2018-06-30 | $22 |
| 2018-03-31 | $19 |
| 2017-12-31 | |
